Using ALBI score at the start of sorafenib treatment to predict regorafenib treatment candidates in patients with hepatocellular carcinomaAtsushi Yukimoto, Yoichi Hiasa, Masashi Hirooka et al.|Japanese Journal of Clinical Oncology|2018Cited by 35
Therapeutic effects of the PKR inhibitor C16 suppressing tumor proliferation and angiogenesis in hepatocellular carcinoma in vitro and in vivoTakao Watanabe, Yoichi Hiasa, Hiroko Ninomiya et al.|Scientific Reports|2020Cited by 33
Comparison between real‐time tissue elastography and vibration‐controlled transient elastography for the assessment of liver fibrosis and disease progression in patients with primary biliary cholangitisYohei Koizumi, Yoichi Hiasa, Masashi Hirooka et al.|Hepatology Research|2017Cited by 30
Intranasal therapeutic vaccine containing HBsAg and HBcAg for patients with chronic hepatitis B; 18 months follow‐up results of phase IIa clinical studyOsamu Yoshida, Yoichi Hiasa, Gerardo Guillén et al.|Hepatology Research|2022Cited by 24
Stimulated hepatic stellate cell promotes progression of hepatocellular carcinoma due to protein kinase R activationYusuke Imai, Yoichi Hiasa, Osamu Yoshida et al.|PLoS ONE|2019Cited by 21